Previous 10 | Next 10 |
home / stock / rhhvf / rhhvf news
2023-12-29 16:11:47 ET Summary Positive results achieved from phase 1 dose expansion study using luveltamab tazevibulin for the treatment of patients with FRa-positive endometrial cancer. Phase 1 dose expansion study, using luveltamab tazevibulin in FRa-positive endometrial cancer...
2023-12-29 14:54:46 ET Summary I review the stocks of five world-class companies that I am convinced will bring me closer to my ambitious goal of being able to fund my living expenses through dividends. I point out the specifics of the companies' business models, discuss their pro...
2023-12-23 04:18:53 ET Summary AbbVie and GSK are both solid investment choices in the biopharmaceutical industry. AbbVie's financials and forward outlook show strong performance alongside solid partnerships, which hint at growth potential. GSK's current financials, product la...
2023-12-20 12:00:32 ET Summary Liquidia Corporation is worth at least $15 in a win. Roivant Sciences is worth at least $12 per share. Burford Capital Limited is worth at least $20 per share. Value & Event Driven Investing I recently spoke for a half an hour a...
2023-12-19 13:13:17 ET Summary TG Therapeutics, Inc. stock has gone up a lot due to a Q3 revenue beat. However, look closely at the Q3 numbers, and you can see Briumvi wasn't responsible for the revenue beat. Briumvi hasn't done as well as it should have. My TG The...
2023-12-06 04:37:12 ET More on Merck KGaA Merck KGaA (MKGAF) Q3 2023 Earnings Call Transcript Merck KGaA: Company With A Potential Upside Exscientia climbs as Merck KGaA joins AI drug discovery Historical earnings data for Merck KGaA Dividend scorecar...
2023-12-05 22:50:05 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2023-12-04 05:44:22 ET Roche ( OTCQX:RHHBY ) announced on Monday a deal to acquire U.S. biotechnology company Carmot Therapeutics for USD 2.7B in cash at closing. Based in Berkeley, California, Carmot specializes in obesity drugs, with a broad pipeline of therapeutics, including thr...
2023-11-29 13:12:25 ET Summary Roche Holdings is a strong player in the pharmaceutical and diagnostics industry, with a focus on oncology and diagnostics, and has shown resilience during the COVID-19 pandemic. The company has demonstrated impressive financial growth, particularly ...
2023-11-19 09:56:29 ET Summary WisdomTree International Quality Dividend Growth Fund selects ex-North America dividend stocks with quality and expected earnings growth characteristics. The fund is well-diversified across countries, sectors, and holdings, with a focus on Europe. ...
News, Short Squeeze, Breakout and More Instantly...
Roche Holding Div Rts Company Name:
RHHVF Stock Symbol:
OTCMKTS Market:
Roche Holding Div Rts Website:
Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care Canada NewsWire At the global HIMSS 1 Conference, Roche showcases navify Algorithm Suite, a single platform offering cli...
Roche Announces Brad Moore as President and CEO of Roche Diagnostics North America PR Newswire INDIANAPOLIS , Dec. 5, 2022 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of Brad Moore as president and CEO of Roche Diagnost...